|Beijing Huitong Dingsheng Touzi Guanli Zhongxin||Beijing, Beijing, China|
|Beijing Pingfeng Kangtai Keji Co., Ltd||Beijing, China, Haidian|
|Edwards Lifesciences||California, Irvine, United States|
|GENTOSHA MediaConsulting||Japan, Tokyo|
|Jinling Chuangtou||China, Shanghai|
|Mandi Ventures||Brazil, São Paulo, Sao Paulo|
|Medytox||Seoul-t'ukpyolsi, South Korea, Yeoksamdong|
|N7 Labs||California, San Diego, United States|
|Razor Capital||England, London, United Kingdom|
|Sand Hill Angels||California, Mountain View, United States|
|Star Mica||Japan, Tokyo|
|Stratus Ventures||Illinois, Northbrook, United States|
|Symphony Technology Group||California, Palo Alto, United States|
|Tianda Pharmaceuticals||China, Hong Kong, Hong Kong Island|
|University of Utah Endowment||Salt Lake City, United States, Utah|
|20 Jul 2022||Shanghai, China|
Container Union Consolidation
|11 Nov 2021||Shanghai, Shanghai, China|
|$12M||04 Mar 2020||China, Wuwei|
|$463K||01 Oct 2018||Shenzhen, Guangdong, China|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.